You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart

Article: PP17 Targeting of the histone methyltransferases G9a and GLP in multiple myeloma

€3.03

SKU: product-article-15347 Category: General

Description

Description

PP17 Targeting of the histone methyltransferases G9a and GLP in multiple myeloma

Top

Article: PP17 Targeting of the histone methyltransferases G9a and GLP in multiple myeloma

Description

Related products

Article: Highlights in respiratory oncology

Article: Highlights in genitourinary cancers

Article: Highlights in digestive oncology

Article: Highlights in urologic cancer